Even Tougher Choices Ahead for Teva After FDA Shocker

A surprise movefrom the Food and Drug Administration means that a recovery for Teva Pharmaceutical Industries just got much more difficult.

from WSJ.com: Markets http://ift.tt/2yYrxsn
via https://ifttt.com/ IFTTT